SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 5
|
records per page:
next > | last >>
|
|
pages:
1
2
3
4
5
|
presentations:
1 to
50 of
202
|
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
THE INFANT GUT: A GREAT DEFENSE SYSTEM?
(ABSTRACT
52)
Andrew Prendergast
Queen Mary University of London, London , United Kingdom
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
MOTHER-TO-CHILD TRANSMISSION OF HTLV-1
(ABSTRACT
53)
Antoine Gessain
Institut Pasteur, Paris, France
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
CAN WE ELIMINATE BREASTMILK TRANSMISSION OF HIV?
(ABSTRACT
54)
Ameena Goga
South African Medical Research Council, Cape Town, South Africa
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
ART IN BREASTMILK: DEFINING THE RISK-BENEFIT RATIO
(ABSTRACT
55)
Catriona Waitt
University of Liverpool, Liverpool, Merseyside, United Kingdom
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
THE GLOBAL BURDEN OF TUBERCULOSIS AND MODELING CONTROL STRATEGIES
(ABSTRACT
56)
Nimalan Arinaminpathy
Imperial College London, London, United Kingdom
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
USING WHOLE GENOME SEQUENCING TO BETTER UNDERSTAND TB TRANSMISSION DYNAMICS
(ABSTRACT
57)
Neel R Gandhi
Emory University, Atlanta, GA, USA
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
UNDIAGNOSED TUBERCULOSIS: PROMISE FOR PREVENTION
(ABSTRACT
58)
Neil A Martinson
Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg., Soweto, Gauteng, South Africa
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
NEW DEVELOPMENTS IN THE MANAGEMENT OF DRUG-RESISTANT TUBERCULOSIS
(ABSTRACT
59)
Serena Koenig
Brigham and Women's Hospital, Boston, MA, USA
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
MECHANISMS OF EARLY CD8+ T CELL CONTROL
(ABSTRACT
48)
Jonah Sacha
Oregon Health & Science University, Portland, OR, USA
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
EARLY BROADLY NEUTRALIZING ANTIBODY TREATMENT LEADING TO T-CELL CONTROL
(ABSTRACT
49)
Malcolm Martin
NIAID, NIH, Bethesda, MD, USA
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
ANTI-ΑLPHA-4/ΒETA-7 ANTIBODY-MEDIATED CONTROL: UNDERSTANDING THE MECHANISM
(ABSTRACT
50)
James Arthos
NIH, Bethesda, MD, USA
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
EARLY INTERVENTION THERAPIES IN HUMANS: ART, ANTIBODIES, AND VACCINES
(ABSTRACT
51)
Eugène Kroon
Thai Red Cross AIDS Research Centre, Bangkok, Thailand
SYMPOSIUM: STRATEGIES FOR IMPROVING THE US CARE CASCADE: CONFRONTING A FRAGMENTED HEALTH SYSTEM
THE EVOLVING HIV EPIDEMIC IN THE UNITED STATES
(ABSTRACT
60)
Carlos del Rio
Emory University, Atlanta, GA, USA
SYMPOSIUM: STRATEGIES FOR IMPROVING THE US CARE CASCADE: CONFRONTING A FRAGMENTED HEALTH SYSTEM
HIV TESTING AND LINKAGE: THE GATEWAY TO TREATMENT AND PREVENTION
(ABSTRACT
61)
Hyman Scott
San Francisco Department of Public Health, San Francisco, CA, USA
SYMPOSIUM: STRATEGIES FOR IMPROVING THE US CARE CASCADE: CONFRONTING A FRAGMENTED HEALTH SYSTEM
HIV CARE ENGAGEMENT: MAXIMIZING INDIVIDUAL AND POPULATION HEALTH
(ABSTRACT
62)
Michael J Mugavero
University of Alabama at Birmingham, Birmingham, AL, USA
SYMPOSIUM: STRATEGIES FOR IMPROVING THE US CARE CASCADE: CONFRONTING A FRAGMENTED HEALTH SYSTEM
SYSTEMS OF CARE FOR VULNERABLE POPULATIONS IN THE UNITED STATES
(ABSTRACT
63)
Julia C Dombrowski
University of Washington, Seattle, WA, USA
SYMPOSIUM: LIFE EXPECTANCY AT 25
SYMPOSIUM CONVENER
Peter W. Hunt
University of California San Francisco, San Francisco, CA, USA
SYMPOSIUM: LIFE EXPECTANCY AT 25
LIFE EXPECTANCY IN THE MODERN ART ERA
(ABSTRACT
102)
Caroline Sabin
University College London, London, United Kingdom
SYMPOSIUM: LIFE EXPECTANCY AT 25
IMPACT OF PHYSICAL AND MENTAL COMORBIDITIES ON LIFE EXPECTANCY
(ABSTRACT
103)
Keri N Althoff
Johns Hopkins University, Baltimore, MD, USA
SYMPOSIUM: LIFE EXPECTANCY AT 25
INFLAMMATION AND DISEASE RISK AMONG HIV-SEROPOSITIVE INDIVIDUALS
(ABSTRACT
104)
Jason V Baker
HCMC / University of Minnesota, Minneapolis, MN, USA
SYMPOSIUM: LIFE EXPECTANCY AT 25
SYMPOSIUM: MOLECULAR MACHINES
SYMPOSIUM CONVENER
Zandrea Ambrose
University of Pittsburgh, Pittsburgh, PA, USA
SYMPOSIUM: MOLECULAR MACHINES
HIV ENV: STRUCTURE, FUNCTION, AND INHIBITION THEREOF
(ABSTRACT
98)
Peter D Kwong
NIH, Bethesda, MD, USA
SYMPOSIUM: MOLECULAR MACHINES
ARCHITECTURE OF THE HIV-1 REVERSE TRANSCRIPTASE INITIATION COMPLEX
(ABSTRACT
99)
Elisabetta Viani Puglisi
Stanford University, Stanford, CA, USA
SYMPOSIUM: MOLECULAR MACHINES
STRUCTURE AND MECHANISM OF THE SAMHD1 HIV-1 RESTRICTION FACTOR
(ABSTRACT
100)
Ian Anthony Taylor
Francis Crick Institute, London, United Kingdom
SYMPOSIUM: MOLECULAR MACHINES
STRUCTURE AND MECHANISM OF VPS4, THE ENZYME THAT DRIVES HIV BUDDING
(ABSTRACT
101)
Christopher P Hill
University of Utah, Salt Lake City, UT, USA
SYMPOSIUM: PrEP WORKS, NOW WHAT?
THE INTERSECTION OF PREP AND SEXUALLY TRANSMITTED INFECTIONS
(ABSTRACT
105)
Julia A Schillinger
US Centers for Disease Control and Prevention, New York, NY, USA
SYMPOSIUM: PrEP WORKS, NOW WHAT?
IMPACT OF PREP ON HIV INCIDENCE
(ABSTRACT
106)
Roel Coutinho
University Medical Center Utreecht, Utrecht, Netherlands
SYMPOSIUM: PrEP WORKS, NOW WHAT?
FIVE CONTROVERSIES IN PREP SCALE UP
(ABSTRACT
107)
Linda-Gail Bekker
University of Cape Town, Cape Town, South Africa
SYMPOSIUM: PrEP WORKS, NOW WHAT?
TAKING THE LEAP IN PREP SCALE-UP: A GOOD TYPE OF CHALLENGE
(ABSTRACT
108)
Nelly R. Mugo
Kenya Medical Research Institute, Nairobi, Kenya
SYMPOSIUM: ART: THE NEXT 25 YEARS
SYMPOSIUM CONVENER
Eric Arts
Western University, London, Ontario, Canada
SYMPOSIUM: ART: THE NEXT 25 YEARS
INTEGRATING NEW ANTIRETROVIRAL THERAPIES
(ABSTRACT
159)
Chloe Orkin
Barts Health NHS Trust, London, United Kingdom
SYMPOSIUM: ART: THE NEXT 25 YEARS
BROADLY NEUTRALIZING ANTIBODIES FOR HIV PREVENTION AND TREATMENT:DREAM OR PIPE DREAM?
(ABSTRACT
160)
Daniel R Kuritzkes
Brigham and Women's Hospital/Harvard Medical School, Cambridge, MA, USA
SYMPOSIUM: ART: THE NEXT 25 YEARS
ANTIRETROVIRAL THERAPY IN CHILDREN: PRESENT CHALLENGES, FUTURE OPPORTUNITIES
(ABSTRACT
161)
Helena Rabie
University of Stellenbosch, Cape Town, South Africa
SYMPOSIUM: ART: THE NEXT 25 YEARS
TRANSITIONING TO NEW GENERIC ANTIRETROVIRALS IN SUB-SAHARAN AFRICA
(ABSTRACT
162)
Tendani Gaolathe
Botswana-Harvard AIDS Institute, Gaborone, Botswana
SYMPOSIUM: EMERGING PRIORITIES IN LIVER DISEASE
THE OPIOID EPIDEMIC AND INFECTIOUS DISEASES: A PUBLIC HEALTH CRISIS
(ABSTRACT
163)
Sally Lynn Hodder
West Virginia University, Morgantown, WV, USA
SYMPOSIUM: EMERGING PRIORITIES IN LIVER DISEASE
GLOBAL ELIMINATION OF HEPATITIS C
(ABSTRACT
164)
Jordan J Feld
Toronto General Hospital, Toronto, ON, Canada
SYMPOSIUM: EMERGING PRIORITIES IN LIVER DISEASE
THE RISING CHALLENGE OF LIVER CANCER
(ABSTRACT
165)
Massimo Giuseppe Colombo
Humanitas Hospital Rozzano, Milan, Italy
SYMPOSIUM: EMERGING PRIORITIES IN LIVER DISEASE
EXPANDING HOPE: ORGAN TRANSPLANTS FROM DONORS WITH HIV OR HCV INFECTION
(ABSTRACT
166)
Christine Durand
Johns Hopkins University School of Medicine, Baltimore, MD, USA
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
MDR-TB EPIDEMIOLOGY AND TRANSMISSION DYNAMICS
N. Sarita Shah
Centers for Disease Control and Prevention, Atlanta, GA, USA
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
EMERGING TREATMENT ISSUES IN MDR-TB
Francesca Conradie
University of the WItswatersrand, Johannesburg, South Africa
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
NEW DIAGNOSTIC TECHNOLOGIES FOR MDR-TB
Catharina C Boehme
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
THE CHALLENGES OF TREATING MDR-TB IN CHILDREN
H. Simon Schaaf
Stellenbosch University, Cape Town, South Africa
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
VAGINAL MICROBIOME AND SUSCEPTIBILITY TO HIV
R. Scott McClelland
University of Washington, Seattle, WA, USA
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
ANTIBIOTIC PROPHYLAXIS FOR STIs: PROMISES OR PERILS
Jean-Michel Molina
Hôpital St Louis, Paris, France
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
SYPHILIS IN THE ERA OF TREATMENT AS PREVENTION AND PRE-EXPOSURE PROPHYLAXIS
Matthew R Golden
University of Washington, Seattle, WA, USA
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
SCALE-UP OF POINT-OF-CARE TESTS FOR SEXUALLY TRANSMISSIBLE INFECTIONS
Rebecca J Guy
Kirby Institute, University of New South Wales, Sydney, Australia
SYMPOSIUM: VISIONS OF HIV CURE
VISUALIZING PERSISTENT HIV IN CLINICAL SAMPLES
Daniel E Kaufmann
University of Montreal, Montreal, Canada
SYMPOSIUM: VISIONS OF HIV CURE
CHARACTERIZING HIV EXPRESSION IN VIVO
Mary F Kearney
National Cancer Institute, National Institutes of Health, Frederick, MD, USA
|
<< first | < prev
page:
of 5
|
records per page:
next > | last >>
|
|
pages:
1
2
3
4
5
|
presentations:
1 to
50 of
202
|
